![]() |
|
|
Vol. 300, Issue 3, 824-830, March 2002
/
/p75
/
) Double Receptor
Knockout Mice Following Phenobarbital Treatment
College of Pharmacy, Division of Pharmaceutical Sciences (P.V.E.,
R.A.B.) and Sanders-Brown Research Center on Aging (M.P.M), University
of Kentucky, Lexington, Kentucky; and Laboratory of Neurosciences,
National Institute on Aging Gerontology Research Center (M.P.M.) and
Department of Neuroscience, Johns Hopkins University School of Medicine
(M.P.M), Baltimore, Maryland
Phenobarbital (PB) is a well characterized inducer of cytochrome
P450 (P450) 2B and 3A subfamilies. Several proinflammatory cytokines have been shown to negatively modulate the induction of P450
by PB. In addition, PB is known to elicit an inflammatory mitogenic
effect on the liver. To date, no studies have evaluated the PB
induction profile of hepatic P450 in the absence of an intact tumor
necrosis factor-alpha (TNF
) response. To test the hypothesis that
endogenous TNF
signaling modulates hepatic P450 induction by PB in
vivo, PB induction was examined in TNF
(p55
/
/p75
/
) double receptor knockout
mice (ko-TNF) and wild-type mice (wt-TNF). CYP2B- and CYP3A-associated
activities and protein content were induced to a significantly greater
extent (p < 0.05) in ko-TNF mice compared with
wt-TNF mice. In parallel with enhanced CYP2B induction, an apparent
elevation in the nuclear accumulation of the principal regulatory
protein for transcription of CYP2B genes, the constitutively activated
receptor (CAR), was detected in ko-TNF nuclear extracts following PB
treatment. Additionally, nuclear factor
-B binding was induced by PB
in wt-TNF mice, but not in ko-TNF mice, indicating that the hepatic
inflammatory response following PB treatment differed between wt-TNF
and ko-TNF mice. These data demonstrate that endogenous TNF
signaling modulates PB induction of hepatic CYP2B and CYP3A isoforms in
vivo. Further, the data presented herein suggest that endogenous TNF
signaling influences PB induction of CYP2B through inhibition of CAR
nuclear accumulation.
This article has been cited by other articles:
![]() |
R. C. Zangar, N. Bollinger, S. Verma, N. J. Karin, and Y. Lu The Nuclear Factor-{kappa}B Pathway Regulates Cytochrome P450 3A4 Protein Stability Mol. Pharmacol., June 1, 2008; 73(6): 1652 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Geier, C. G. Dietrich, S. Voigt, M. Ananthanarayanan, F. Lammert, A. Schmitz, M. Trauner, H. E. Wasmuth, D. Boraschi, N. Balasubramaniyan, et al. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G831 - G841. [Abstract] [Full Text] [PDF] |
||||